Response
| Response . | Clofarabine, no. (%) . | Clofarabine + LD cytarabine, no. (%) . | Total, no. (%) . | P . |
|---|---|---|---|---|
| Number in group | 16 | 54 | 70 | |
| CR | 5 (31) | 34 (63) | 39 (56) | .025 |
| CRi | 0 | 2 (4) | 2 (3) | |
| OR | 5 (31) | 36 (67) | 41 (59) | .012 |
| Treatment failure | 6 (38) | 8 (19) | 14 (20) | .046 |
| Induction mortality | 5 (31) | 10 (19) | 15 (21) | .276 |
| Response . | Clofarabine, no. (%) . | Clofarabine + LD cytarabine, no. (%) . | Total, no. (%) . | P . |
|---|---|---|---|---|
| Number in group | 16 | 54 | 70 | |
| CR | 5 (31) | 34 (63) | 39 (56) | .025 |
| CRi | 0 | 2 (4) | 2 (3) | |
| OR | 5 (31) | 36 (67) | 41 (59) | .012 |
| Treatment failure | 6 (38) | 8 (19) | 14 (20) | .046 |
| Induction mortality | 5 (31) | 10 (19) | 15 (21) | .276 |
LD indicates low-dose.
The P value of each row indicates comparison between treatment arms within each response category.